Alyeska Investment Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.6M | Buy |
+203,868
| New | +$21.6M | 0.08% | 271 |
|
|
2025
Q1 | – | Sell |
-228,101
| Closed | -$28.1M | – | 582 |
|
|
2024
Q4 | $28.1M | Buy |
+228,101
| New | +$28.1M | 0.11% | 221 |
|
|
2021
Q1 | – | Sell |
-4,691
| Closed | -$774K | – | 767 |
|
|
2020
Q4 | $774K | Sell |
4,691
-123,243
| -96% | -$20.3M | 0.01% | 423 |
|
|
2020
Q3 | $18.2M | Sell |
127,934
-77,516
| -38% | -$11.1M | 0.28% | 111 |
|
|
2020
Q2 | $22.7M | Buy |
205,450
+199,452
| +3,325% | +$22M | 0.34% | 104 |
|
|
2020
Q1 | $598K | Buy |
+5,998
| New | +$598K | 0.01% | 304 |
|
|
2019
Q4 | – | Sell |
-5,124
| Closed | -$657K | – | 419 |
|
|
2019
Q3 | $657K | Buy |
+5,124
| New | +$657K | 0.01% | 317 |
|
|
2016
Q3 | – | Sell |
-352,399
| Closed | -$49.8M | – | 476 |
|
|
2016
Q2 | $49.8M | Buy |
352,399
+103,946
| +42% | +$14.7M | 0.47% | 73 |
|
|
2016
Q1 | $32.4M | Buy |
248,453
+237,210
| +2,110% | +$31M | 0.3% | 131 |
|
|
2015
Q4 | $1.58M | Sell |
11,243
-218,587
| -95% | -$30.7M | 0.02% | 309 |
|
|
2015
Q3 | $30.5M | Buy |
229,830
+77,384
| +51% | +$10.3M | 0.36% | 107 |
|
|
2015
Q2 | $26.8M | Buy |
152,446
+87,366
| +134% | +$15.4M | 0.3% | 113 |
|
|
2015
Q1 | $11.2M | Buy |
+65,080
| New | +$11.2M | 0.16% | 206 |
|